Skip to main content

Published locations for Genentech submits sNDA for venetoclax in untreated AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Genentech submits sNDA for venetoclax in untreated AML

User login

  • Reset your password
  • /content/genentech-submits-snda-venetoclax-untreated-aml
  • /hematologynews/article/170145/aml/genentech-submits-snda-venetoclax-untreated-aml
  • /oncologypractice/article/170145/aml/genentech-submits-snda-venetoclax-untreated-aml
  • /hematology-oncology/article/170145/aml/genentech-submits-snda-venetoclax-untreated-aml
  • /b-cell-lymphoma-icymi/article/170145/aml/genentech-submits-snda-venetoclax-untreated-aml